首页> 外文OA文献 >Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy

【2h】

Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy

机译：在治疗BRCA突变的卵巢癌中的奥拉帕里布的聚焦：在治疗中的设计，开发和放置

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Domenica Lorusso; Elisa Tripodi; Giuseppa Maltese; Stefano Lepori; Ilaria Sabatucci; Giorgio Bogani; Francesco Raspagliesi;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy [J] . Domenica Lorusso, Elisa Tripodi, Giuseppa Maltese, Drug Design, Development and Therapy . 2018,第InaProgress期

机译：奥拉帕尼在BRCA突变型卵巢癌治疗中的作用：设计，开发和治疗方法
2. FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy [J] . Kim Geoffrey, Ison Gwynn, Mckee Amy E., Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第19期

机译：FDA批准摘要：使用三行或更多行化学疗法治疗有害生殖系BRCA突变的晚期卵巢癌患者的Olaparib单药治疗
3. FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy [J] . Geoffrey Kim, Gwynn Ison, Amy E. McKee, Cancer reviews . 2015,第Nova期

机译：FDA批准摘要：Olaparib单药治疗有害种系BRCA-突变的晚期卵巢癌治疗，用三种或更多种化疗进行治疗
4. Synergistic effects of laser and adjuvant therapies for cancer - Progress in the development of novel cancer treatment methods using combinations of photothermal, photochemical, immunotherapy and chemotherapy [C] . Wei R. Chen, Kenneth E. Bartels, Mladen Korbelik, Optical Interactions with Tissue and Cells XVI; Progress in Biomedical Optics and Imaging; vol.6, no.10 . 2005

机译：激光和辅助疗法对癌症的协同效应-结合光热，光化学，免疫疗法和化学疗法开发新型癌症治疗方法的进展
5. Nanomedicines and Combination Therapy of Doxorubicin and Olaparib for Treatment of Ovarian Cancer. [D] . Eetezadi, Sina. 2016

机译：阿霉素和奥拉帕比的纳米药物和联合疗法治疗卵巢癌。
6. Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design development and place in therapy [O] . Domenica Lorusso, Elisa Tripodi, Giuseppa Maltese, 2018

机译：奥拉帕尼治疗BRCA突变型卵巢癌的研究：设计开发和在治疗中的应用
7. 33 Olaparib monotherapy versus (VS) chemotherapy for germline BRCA-mutated (GBRCAM) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (PTS): phase III solo3 trial [O] . RT Penson, RV Valencia, D Cibula, 2019

机译：33奥拉帕里布单疗法对（对）种子BRCA突变的（GBRCAM）铂敏感复发卵巢癌（PSR OC）患者（PTS）：III期SOLO3试验

Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy

著录项

引文网络

相似文献

相关主题

期刊订阅